Imaging Technology

APRIL 24, 2024

Microglia are immune cells in the brain that are thought to have a role in MS disease progression but cannot be seen by a routine MRI. The team developed a technique called F18 PBR 06 PET imaging. The newly published study involved performing PET scans on 22 people with MS and eight healthy controls.

PET Scan 74

PET Scan Disease Nuclear Medicine Clinic 74

AuntMinnie

JANUARY 30, 2024

FDG-PET imaging shows promise for use as a diagnostic criterion for neurosarcoidosis, with a recent case series illustrating the approach was effective when gold-standard approaches were not, according to a group of researchers in Berlin. “To In all three cases, gadolinium-enhanced MRI scans did not show abnormalities.

Diagnose 97

Diagnose PET Scan MRI Disease 97

AuntMinnie

OCTOBER 18, 2023

A group in France has offered an explanation for long COVID brain fog, with the concept based on a visual brain pattern they discovered on patient PET scans, according to a study published October 13 in Medical Hypotheses. “We A) PET scan of a healthy subject. (B) B) PET scan of a long COVID patient.

PET Scan 145

PET Scan Nuclear Medicine Hospital Imaging 145

AuntMinnie

FEBRUARY 19, 2024

In this case, a 43-year-old man underwent an MRI scan that showed no contrast enhancement, yet hyperintensities were apparent in the patient’s left thalamus and frontoparietal region. Thus, the clinicians performed an additional PET scan with an amino acid radiotracer (F-18 FET) for further diagnosis of a suspected glioma.

Nuclear Medicine 105

Nuclear Medicine PET Scan Imaging MRI 105

Vesta Teleradiology

DECEMBER 29, 2023

Long COVID In a study published in Medical Hypotheses , a French group presented a theory regarding the brain fog experienced in long COVID, based on brain patterns identified in patient PET scans. Further prospective longitudinal MRI studies are essential to elucidate causality in this context.

Imaging 52

Imaging Radiation PET Scan MRI 52

Imaging Technology

MAY 30, 2023

POSLUMA is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer with suspected metastasis who are candidates for initial definitive therapy or with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.

Diagnostic 75

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 75